Infektsii mochevyvodyashchikh putey u beremennykh: effektivnost' primeneniya fosfomitsina
- Authors: Mozgovaya E.V1, Patrukhina N.A1
-
Affiliations:
- Issue: No 4 (2014)
- Pages: 23-27
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286675
- ID: 286675
Cite item
Open Access
Access granted
Abstract
Urinary tract infection (UTI) is a frequent gestational complication. During pregnancy, lack of timely and adequate treatment of lower UTI leads to the development of gestational pyelonephritis, miscarriage, and perinatal morbidity. Highly virulent uropathogenic flora, limitation in the choice of antibiotics and increasing antibiotic resistance of microbial agents create difficulties in sanitation of the urinary tract during pregnancy. Fosfomycin trometamol (Monural) was applied in 85 pregnant women with UTI in the 2nd and 3rd trimesters, and has proved high efficacy in the sanitation of lower urinary tract in single dose and effective prevention of relapse of chronic pyelonephritis with repeated dosing.
Keywords
Full Text
References
- Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am. J. Med. 2002;113(Suppl. 1A):5S-13S.
- Anto E.M., Wieler L.H., Ewers C. Adhesive threads of extraintestinal pathogenic Escherichia coli. Gut Pathog. 2009:10:1-22.
- Krcmery S., Hromec J., Demesova D. Treatment of lower urinary tract infection in pregnancy. Int. J. Antimicrob. Agents. 2001;17:279-82.
- Kass E.H. Bacteriuria and pyelonephritis of pregnancy. Arch. Intern. Med. 1960;105:194-98.
- Франц М., Хорл У. Наиболее частые ошибки диагностики и ведения инфекции мочевых путей (ИМП). Нефрология и диализ. 2002; 2(4):340-47.
- Guay D.R.P. Contemporary management of uncomplicated urinary tract infections. Drugs 2008;68:1169-205.
- Никонов А.П., Асцатурова О.Р., Каптильный В.А. Инфекции мочевыводящих путей и беременность. Гинекология. 2007;(1). www. consiliummedicum.com
- Stapleton A. Novel approaches to prevention of urinary tract infections.Infect. Dis. Clin. North. Am. 2003;17:457-71.
- Gagliotti C., Buttazzi R., Sforza S., et al. Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli. J. Infect. 2008;57:179-84.
- Rubin R.H., Shapiro E.D., Andriole V.T., Davis R.J., Stamm W.E. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 1999;15(Suppl 1):S216-27.
- Smaill F., Vazquez J.C. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst. Rev. 2007;(2):CD000490.
- Vazquez J.C., Villar J. Treatments for symptomatic urinary tract infections during pregnancy. Cochrane Database Syst. Rev. 2000;(3):CD002256.
- Roussos N., Karageorgopoulos D.E., Samonis G., et al. Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections. Int. J. Antimicrob. Agents. 2009;34:506-15.
- Многоцентровое исследование динамики антибиотикорезистентности возбудителей инфекций мочевых путей в различных субпопуляциях пациентов ДАРМИС. Смоленск, 2011. 118 с.
- Guinto V.T., De Guia B., Festin M.R., Dowswell T. Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy. Cochrane Database Syst. Rev. 2010;8:CD007855.
- Estebanez A., Pascual R., Gil V., et al. Fosfomycin in a single dose versus a 7-day course of amoxicillin-clavulanate for the treatment of asymptomatic bacteriuria during pregnancy. Eur. J. Clin. Microbiol. Infect. Dis. 2009;28:1457-64.
- Bayrak O., Cimentepe E., Inegol I., et al. Is singledose fosfomycin trometamol a good alternative for asymptomatic bacteriuria in the second trimester of pregnancy? Int. Urogynecol. J. Pelvic Floor Dysfunct. 2007;18:525-29.
- Falagas1 M.E., Vouloumanou1 E.K., Togias A.G., et al. Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials. J Antimicrob. Chemother. 2010;65:1862-77.
- Reeves D.S. Clinical efficacy and safety of fosfomycin trometamol in the prevention and treatment of urinary tract infection. Rev Contemp Pharmacother. 1995;6:71-83.
- Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect. Dis. Clin. North. Am. 2003;17:243-59.
Supplementary files
